                </a></li></ul></div><p><strong>Figure 4.  <span>LCMV-GP specific peptide tolerisation does not affect antibody production against third party pathogen.</span></strong></p><a id="article1.body1.sec2.sec4.fig1.caption1.p1" name="article1.body1.sec2.sec4.fig1.caption1.p1"></a><p>C57BL/6 were tolerised with 100 µg GP61-IFA at day -9, -6 and -3. At day 0, mice were infected with 2×10<sup>6</sup> PFU of vesicular stomatitis virus (VSV). Neutralizing antibodies against VSV-glycoprotein were measured by VSV neutralisation assay; total neutralizing Ig (A) and neutralizing IgG (B). VSV-glycoprotein binding IgG was measured by ELISA (C).</p>
<span>THISISTHEEND
